Sleep intervention and glycemic control in gestational diabetes mellitus: a feasibility study.

BACKGROUND: Over 50% of pregnant people report poor sleep quality and insomnia, with approximately 25% reporting short sleep (<7 hours per night). Short sleep duration is associated with impaired glucose functioning, insulin resistance, and type 2 diabetes mellitus. Although short sleep is associated with elevated blood glucose in patients with gestational diabetes mellitus, it is not known whether education on healthy sleep habits during pregnancy can improve sleep and thus glycemic control in these patients. OBJECTIVE: We developed a sleep education program specific to pregnancy and targeted to patients with gestational diabetes mellitus. We aimed to evaluate the feasibility of this intervention in the setting of a randomized controlled trial. STUDY DESIGN: A sleep education program specific to pregnancy, "Sleep-4-2," was developed via multidisciplinary collaboration between specialists in maternal-fetal medicine, sleep medicine, and psychiatry. The program was presented to focus groups of pregnant people and a separate group of healthcare providers to gauge acceptability of the program and to modify content. This program was then tested on a group of patients diagnosed with gestational diabetes mellitus. Participants were randomized to a group receiving standard gestational diabetes mellitus care or a group participating in the sleep education program. Baseline demographics, sleep knowledge, and self-reported sleep quality information were obtained from all participants at enrollment and again at 35 weeks of pregnancy. Change in sleep knowledge and quality and degree of glycemic control were compared between groups. RESULTS: Between December 2017 and July 2019, 140 patients were screened and 74 were enrolled in the study and randomized. Recruitment to the study was acceptable, with >50% of eligible approached patients agreeing to participate, and retention in the intervention group was high at 94%. We did not demonstrate any difference in sleep knowledge or in the proportion of patients achieving glycemic control during pregnancy. CONCLUSION: Implementation of a sleep education program specific to pregnancy for patients with gestational diabetes mellitus was feasible in the context of typical care. A definitive trial could be developed on the basis of this pilot study to evaluate whether a sleep intervention in pregnancy can improve glycemic control in patients with gestational diabetes mellitus.

Pre-pregnancy maternal obesity and the risk of preterm preeclampsia in the American primigravida.

OBJECTIVE: To estimate the risk of preterm preeclampsia in primiparous women by pre-pregnancy obesity class. METHODS: A retrospective cohort study of primiparous women with singleton gestations was performed for deliveries from January 2003 to April 2014. Cases were stratified by delivery occurring either at ≥ 37 weeks or < 37 weeks. Pre-pregnancy maternal obesity was defined as a body mass index (BMI) ≥ 30 kg/m(2) . World Health Organization criteria were used to define BMI class of obesity. Multinomial logistic regression modeling estimated the association between term and preterm preeclampsia and pre-pregnancy obesity. RESULTS: Of 28,361 women with complete pre-pregnancy BMI data, 2,588 women (9.1%) had a diagnosis of preeclampsia. Women who developed preeclampsia prior to 37 weeks (n = 784) were more likely to be women with obesity compared to women who developed preeclampsia after 37 weeks (33.1% vs. 25.3%, P = 0.0001). Compared to normal-weight women without preeclampsia, the risk of preterm preeclampsia increased proportionally with pre-pregnancy obesity class, with women with a BMI ≥ 40 kg/m(2) having the greatest risk (RR 5.23, 95% CI: 3.86-7.09, P <0.001). CONCLUSIONS: The risk of preterm preeclampsia increased significantly as the severity of maternal pre-pregnancy obesity increased. Reduction in maternal pre-pregnancy BMI may be protective in mitigating such risk.

Sleep Duration and Blood Glucose Control in Women With Gestational Diabetes Mellitus.

OBJECTIVE: To describe the relationship between objectively assessed sleep and blood glucose in a prospective cohort of women recently diagnosed with gestational diabetes mellitus (GDM). METHODS: Women with GDM were enrolled immediately after attending a GDM education class. All patients were recruited during their first week of attempted dietary management of GDM. They were instructed on the use of a glucometer and on the principles of a GDM diet. Women wore an actigraph and completed a sleep log for 7 consecutive days. Glucose records were compared against the objective sleep data. Linear mixed model analysis was used to estimate the association of sleep duration on morning fasting and 1-hour postprandial blood glucose concentrations. RESULTS: Thirty-seven participants provided data for 213 sleep intervals that corresponded to at least one glucose reading. Sleep duration was negatively associated with fasting and 1-hour postprandial blood glucose concentrations In analyses adjusted for age, gestational age, and body mass index, a 1-hour increase in sleep time was associated with statistically significant reductions in fasting glucose (-2.09 mg/dL, 95% confidence interval [CI] -3.98 to -0.20) as well as postprandial glucose concentrations (lunch -4.62 mg/dL, 95% CI -8.75 to -0.50; dinner -6.07 mg/dL, 95% CI -9.40 to -2.73). CONCLUSION: Short sleep durations are associated with worsened glucose control in women with gestational diabetes. Educating women on healthy sleep and screening for and treating sleep disorders during pregnancy may have a role in optimizing blood glucose control in gestational diabetes. LEVEL OF EVIDENCE: II.

Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.

OBJECTIVE: The objective of the study was to compare the pharmacokinetics of 2 g and 3 g doses of cefazolin when used for perioperative prophylaxis in obese gravidae undergoing cesarean delivery. STUDY DESIGN: We performed a double-blinded, randomized controlled trial from August 2013 to April 2014. Twenty-six obese women were randomized to receive either 2 or 3 g intravenous cefazolin within 30 minutes of a skin incision. Serial maternal plasma samples were obtained at specific time points up to 8 hours after drug administration. Umbilical cord blood was obtained after placental delivery. Maternal adipose samples were obtained prior to fascial entry, after closure of the hysterotomy, and subsequent to fascial closure. Pharmacokinetic parameters were determined via noncompartmental analysis. RESULTS: The median area under the plasma concentration vs time curve was significantly greater in the 3 g group than in the 2 g group (27204 µg/mL per minute vs 14058 µg/mL per minute; P = .001). Maternal plasma concentrations had an impact by body mass index. For every 1 kg/m(2) increase in body mass index at the time of the cesarean delivery, there was an associated 13.77 µg/mL lower plasma concentration of cefazolin across all time points (P = .01). By the completion of cesarean delivery, cefazolin concentrations in maternal adipose were consistently above the minimal inhibitory concentration for both Gram-positive and Gram-negative bacteria with both the 2 g and 3 g doses. The median umbilical cord blood concentrations were significantly higher in the 3 g vs the 2 g group (34.5 µg/mL and 21.4 µg/mL; P = .003). CONCLUSION: Cefazolin concentrations in maternal adipose both at time of hysterotomy closure and fascial closure were above the minimal inhibitory concentration for both Gram-positive and Gram-negative bacteria when either 2 g or 3 g cefazolin was administered as perioperative surgical prophylaxis. Maternal cefazolin concentrations in plasma and maternal adipose tissue are related to both dose and body mass index.

Decreasing retinol and α-tocopherol concentrations in human milk and infant formula using varied bottle systems.

Expressing human milk has become a more common alternative for mothers, as the average work demand has increased. As more mothers must work, bottle feeding trends are increasingly common. The handling and storage of human milk introduce the risk of degradation to expressed human milk and infant formula. In following a 20-minute simulated feeding, Vitamin C has been found to degrade. Vitamin C acts as an anti-oxidant and is responsible for shielding other nutrients from oxidation, such as retinol and alpha-tocopherol. By analyzing a 20-minute simulated feeding, retinol and alpha-tocopherol each displayed decreases over time significantly different than that of the Control, which was milk not exposed to bottle feeding. In human milk, retinol showed as high as a 9.5% decrease compared to the Control. Similar trends were seen with the infant formula samples. The correlation between degradation and bottle feeding systems was dependent upon the formation of bubbles in the milk as the milk was removed from the bottle. The analysis indicated a decrease of up to 12%, as seen in retinol, and 35%, as seen in alpha-tocopherol. These decreases in retinol and alpha-tocopherol should be considered when using a bottle feeding system to deliver either human milk or formula to an infant. More research is necessary to determine the effect of this decrease on the nutritional status of infants, particularly premature infants, who are at higher risk for nutrient deficiencies.